Intramural delivery of Sirolimus prevents vascular remodeling following balloon injury

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1774, Issue 1, 2007, Pages 5-15

  Buerke, Michael ^a   Guckenbiehl, Markus ^a   Schwertz, Hansjörg ^a   Buerke, Ute ^a   Hilker, Michael ^c   Platsch, Herbert ^d   Richert, Joachim ^d   Bomm, Sabine ^d   Zimmerman, Guy A ^e   Lindemann, Stephan ^e   Mueller Werdan, Ursula ^a   Werdan, Karl ^a   Darius, Harald ^b   Weyrich, Andrew S ^e  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^b Department of Cardiology   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d BASF SE   (Germany)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

2D proteome analysis; Angioplasty; Neointima formation; Sirolimus; Vascular injury

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA ACTIN; ALPHA ENOLASE; COLLAGEN TYPE 3; ELASTIN; FIBRONECTIN; LAMIN A; LIPOCORTIN 1; LIPOCORTIN 5; RAPAMYCIN; SCLEROPROTEIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; VIMENTIN ALPHA 1;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL TISSUE; ARTERY WALL; ARTICLE; BALLOON CATHETER; BLOOD VESSEL INJURY; BLOOD VESSEL WALL; CELL PROLIFERATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; ILIAC ARTERY; IMMUNOHISTOCHEMISTRY; INTIMA; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RABBIT; RESTENOSIS; SMOOTH MUSCLE FIBER; SYSTEMATIC REVIEW; VASODILATATION;

ACTINS; ALPHA 1-ANTITRYPSIN; ANGIOPLASTY, BALLOON; ANIMALS; CELL PROLIFERATION; COLLAGEN TYPE III; EXTRACELLULAR MATRIX; FIBRONECTINS; GRAFT OCCLUSION, VASCULAR; ILIAC ARTERY; LAMININ; MALE; MUSCLE, SMOOTH, VASCULAR; RABBITS; SIROLIMUS; TUNICA INTIMA; VIMENTIN;

ORYCTOLAGUS CUNICULUS;

EID: 33846089001     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2006.04.018     Document Type: Article

References (42)

1. Fuster V., Falk E., Fallon J.T., Badimon L., Chesebro J.H., and Badimon J.J. The three processes leading to post PTCA restenosis: dependence on the lesion substrate. Thromb. Haemost. 74 (1995) 552-559
2. Landau C., Lange R.A., and Hillis L.D. Percutaneous transluminal coronary angioplasty. N. Engl. J. Med. 330 (1994) 981-993
3. Gibbons G.H., and Dzau V.J. The emerging concept of vascular remodeling. N. Engl. J. Med. 330 (1994) 1431-1438
4. Li D.Y., Brooke B., Davis E.C., Mecham R.P., Sorensen L.K., Boak B.B., Eichwald E., and Keating M.T. Elastin is an essential determinant of arterial morphogenesis. Nature 393 (1998) 276-280
5. Tai J.T., Brooks E.E., Liang S., Somogyi R., Rosete J.D., Lawn R.M., and Shiffman D. Determination of temporal expression patterns for multiple genes in the rat carotid artery injury model. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2184-2191
6. Raines E.W. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int. J. Exp. Pathol. 81 (2000) 173-182
7. Zohlnhofer D., Klein C.A., Richter T., Brandl R., Murr A., Nuhrenberg T., Schomig A., Baeuerle P.A., and Neumann F.J. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy: detection of FK506-binding protein 12 upregulation. Circulation 103 (2001) 1396-1402
8. Popov N., Schmitt M., Schulzeck S., and Matthies H. Reliable micromethod for determination of the protein content in tissue homogenates. Acta Biol. Med. Ger. 34 (1975) 1441-1446
9. Heukeshoven J., and Dernick R. Improved silver staining procedure for fast staining in PhastSystem Development Unit. I. Staining of sodium dodecyl sulfate gels. Electrophoresis 9 (1988) 28-32
10. Sousa J.E., Costa M.A., Abizaid A., Abizaid A.S., Feres F., Pinto I.M., Seixas A.C., Staico R., Mattos L.A., Sousa A.G., Falotico R., Jaeger J., Popma J.J., and Serruys P.W. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 (2001) 192-195
11. Sousa J.E., Costa M.A., Abizaid A.C., Rensing B.J., Abizaid A.S., Tanajura L.F., Kozuma K., Van Langenhove G., Sousa A.G., Falotico R., Jaeger J., Popma J.J., and Serruys P.W. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 104 (2001) 2007-2011
12. Rensing B.J., Vos J., Smits P.C., Foley D.P., van den Brand M.J., van der Giessen W.J., de Feijter P.J., and Serruys P.W. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up. Eur. Heart J. 22 (2001) 2125-2130
13. Abraham R.T., and Wiederrecht G.J. Immunopharmacology of rapamycin. Annu. Rev. Immunol. 14 (1996) 483-510
14. Gregory C.R., Huie P., Billingham M.E., and Morris R.E. Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels. Transplantation 55 (1993) 1409-1418
15. Meiser B.M., Billingham M.E., and Morris R.E. Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease. Lancet 338 (1991) 1297-1298
16. Guba M., von Breitenbuch P., Steinbauer M., Koehl G., Flegel S., Hornung M., Bruns C.J., Zuelke C., Farkas S., Anthuber M., Jauch K.W., and Geissler E.K. Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor. Nat. Med. 8 (2002) 128-135
17. Morice W.G., Brunn G.J., Wiederrecht G., Siekierka J.J., and Abraham R.T. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1/S-phase growth arrest in T lymphocytes. J. Biol. Chem. 268 (1993) 3734-3738
18. Albers M.W., Brown E.J., Tanaka A., Williams R.T., Hall F.L., and Schreiber S.L. An FKBP-rapamycin-sensitive, cyclin-dependent kinase activity that correlates with the FKBP-rapamycin-induced G1 arrest point in MG-63 cells. Ann. N. Y. Acad. Sci. 696 (1993) 54-62
19. Gingras A.C., Raught B., and Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15 (2001) 807-826
20. Weyrich A.S., Dixon D.A., Pabla R., Elstad M.R., McIntyre T.M., Prescott S.M., and Zimmerman G.A. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 5556-5561
21. Gallo R., Padurean A., Jayaraman T., Marx S., Roque M., Adelman S., Chesebro J., Fallon J., Fuster V., Marks A., and Badimon J.J. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Circulation 99 (1999) 2164-2170
22. Burke S.E., Lubbers N.L., Chen Y.W., Hsieh G.C., Mollison K.W., Luly J.R., and Wegner C.D. Neointimal formation after balloon-induced vascular injury in Yucatan minipigs is reduced by oral rapamycin. J. Cardiovasc. Pharmacol. 33 (1999) 829-835
23. Strauss B.H., Chisholm R.J., Keeley F.W., Gotlieb A.I., Logan R.A., and Armstrong P.W. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res. 75 (1994) 650-658
24. Ju H., and Dixon I.M. Extracellular matrix and cardiovascular diseases. Can. J. Cardiol. 12 (1996) 1259-1267
25. Lafont A., Durand E., Samuel J.L., Besse B., Addad F., Levy B.I., Desnos M., Guerot C., and Boulanger C.M. Endothelial dysfunction and collagen accumulation: two independent factors for restenosis and constrictive remodeling after experimental angioplasty. Circulation 100 (1999) 1109-1115
26. Imanaka-Yoshida K., Matsuura R., Isaka N., Nakano T., Sakakura T., and Yoshida T. Serial extracellular matrix changes in neointimal lesions of human coronary artery after percutaneous transluminal coronary angioplasty: clinical significance of early tenascin-C expression. Virchows Arch. 439 (2001) 185-190
27. Pradet-Balade B., Boulme F., Beug H., Mullner E.W., and Garcia-Sanz J.A. Translation control: bridging the gap between genomics and proteomics?. Trends Biochem. Sci. 26 (2001) 225-229
28. Lindemann S., Tolley N.D., Dixon D.A., McIntyre T.M., Prescott S.M., Zimmerman G.A., and Weyrich A.S. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J. Cell Biol. 154 (2001) 485-490
29. Lindemann S., Tolley N.D., Eyre J.R., Kraiss L.W., Mahoney T.M., and Weyrich A.S. Integrins regulate the intracellular distribution of eukaryotic initiation factor 4E in platelets. A checkpoint for translational control. J. Biol. Chem. 276 (2001) 33947-33951
30. Kraiss L.W., Weyrich A.S., Alto N.M., Dixon D.A., Ennis T.M., Modur V., McIntyre T.M., Prescott S.M., and Zimmerman G.A. Fluid flow activates a regulator of translation, p70/p85 S6 kinase, in human endothelial cells. Am. J. Physiol, Heart Circ. Physiol. 278 (2000) H1537-H1544
31. Dixon D.A., Tolley N.D., King P.H., Nabors L.B., McIntyre T.M., Zimmerman G.A., and Prescott S.M. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest. 108 (2001) 1657-1665
32. Dyer J.A., Kill I.R., Pugh G., Quinlan R.A., Lane E.B., and Hutchison C.J. Cell cycle changes in A-type lamin associations detected in human dermal fibroblasts using monoclonal antibodies. Chromosome Res. 5 (1997) 383-394
33. Kocher O., Gabbiani F., Gabbiani G., Reidy M.A., Cokay M.S., Peters H., and Huttner I. Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimal thickening. Biochemical and morphologic studies. Lab. Invest. 65 (1991) 459-470
34. Worth N.F., Rolfe B.E., Song J., and Campbell G.R. Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins. Cell Motil. Cytoskelet. 49 (2001) 130-145
35. Inoue K., Nakamura N., Kakio T., Suyama H., Tanaka S., Goto Y., Nakazawa Y., Yamamoto Y., and Nagamatsu T. Serial changes of coronary arteries after percutaneous transluminal coronary angioplasty: histopathological and immunohistochemical study. J. Cardiol. 24 (1994) 279-291
36. Hawkins T.E., Merrifield C.J., and Moss S.E. Calcium signaling and annexins. Cell Biochem. Biophys. 33 (2000) 275-296
37. Babiychuk E.B., and Draeger A. Annexins in cell membrane dynamics. Ca(2+)-regulated association of lipid microdomains. J. Cell Biol. 150 (2000) 1113-1124
38. Dabbagh K., Laurent G.J., Shock A., Leoni P., Papakrivopoulou J., and Chambers R.C. Alpha-1-antitrypsin stimulates fibroblast proliferation and procollagen production and activates classical MAP kinase signalling pathways. J. Cell. Physiol. 186 (2001) 73-81
39. Mounkes L.C., Burke B., and Stewart C.L. The A-type lamins: nuclear structural proteins as a focus for muscular dystrophy and cardiovascular diseases. Trends Cardiovasc. Med. 11 (2001) 280-285
40. Dichtl W., Moraga F., Ares M.P., Crisby M., Nilsson J., Lindgren S., and Janciauskiene S. The carboxyl-terminal fragment of alpha1-antitrypsin is present in atherosclerotic plaques and regulates inflammatory transcription factors in primary human monocytes. Mol. Cell Biol. Res. Commun. 4 (2000) 50-61
41. Marx S.O., Jayaraman T., Go L.O., and Marks A.R. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ. Res. 76 (1995) 412-417
42. Yost C.C., Denis M.M., Lindemann S., R.F.J., M.G.K., Buerke M., McIntyre T.M., Weyrich A.S., and Zimmerman G.A. Activated polymorphonuclear leucocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events. J. Exp. Med. 200 (2004) 671-680